- Bupa Platinum consultant
-
Fee assured
-
Verified account
- Open Referral network
Offers
- Face-to-face consultations
- Video and telephone consultations
About me
Dr Colaco is a consultant clinical oncologist with a specialist interest in proton therapy,stereotactic radiotherapy and adult primary brain tumours.
He also specialises in stereotactic radiotherapy for brain metastases and oligo-metastatic cancers including spine and bone metastases.
After completing his training as a specialist registrar in Clinical Oncology at the Christie, Dr Colaco was selected as the first UK doctor to train in proton therapy spending 12 months working in proton therapy at the University of Florida Proton Therapy Institute in Jacksonville, Florida.
He subsequently became the first graduate of the Stereotactic Radiosurgery and Radiotherapy program at Yale University in Connecticut, USA where he spent a further year training in stereotactic radiotherapy.
At Yale, he worked with a variety of radiotherapy delivery platforms including the Cyberknife, Gammaknife and Novalis TX treating patients with stereotactic radiosurgery(SRS) for brain metastases and stereotactic ablative radiotherapy (SABR) for both primary lung tumours and oligo-metastatic disease from other primary cancer sites.
Following his return from the United States, he was appointed as a consultant clinical oncologist at The Christie where he specialises in the treatment of adult brain tumours along with stereotactic radiotherapy for brain metastases and oligo-metastases.
He also sees patients for proton therapy and was involved in the development of The Christie proton beam centre and in setting up the Christie program for oligo-metastatic disease including treating tumours which have metastasised to bone, spine and lymph nodes with SABR.
Dr Colaco has served as co chair for the CNS and skull base committee of the particle therapy co operative group (PTCOG) and on the UK SABR consortium including leading the Royal College of Radiologists spine SABR day teaching UK clinical oncologists stereotactic radiotherapy to the spine.
Research Interest
Proton therapy, stereotactic radiotherapy, CNS tumours –
Dr Colaco has been invited to present an multiple national and international conferences.
He was an invited plenary speaker at the ISRS (International Stereotactic Radiosurgery society) meeting and has led collaborative international research work involving multiple proton centres around the world.
He has published several papers on the use of proton therapy and stereotactic radiotherapy for a variety of cancer sites.
He was the principal investigator at the Christie for the CORE trial which examined the role of stereotactic radiotherapy in oligo-metastatic breast, lung and prostate cancers
Areas of interest
Stereotactic radiosurgery; brain metastasis; primary brain tumours; oligometastatic disease; bone metastasis; stereotactic radiotherapy; proton therapy
Medical secretaries
- Rebecca Mchugh
- 0161 446 3357
- rebecca.mchugh2@nhs.net
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X0004
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-28 days - (5-50)
-
X6950
Clinical supervision of the planning of stereotactic radiosurgery e.g. SRT/SBRT and Gamma Knife - (5-50)
-
A0380
Stereotactic radiotherapy (SRT) using GammaKnife or similar SRT technology - (5-50)
-
X0007
Clinical supervision of external beam radiotherapy, up to and including 15 fractions or part thereof - (5-50)
-
X0002
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-14 days - (1-5)
-
X6772
Preparation for complex radiotherapy with Intensity Modulated Radiotherapy (IMRT) - (1-5)
-
A1080
Stereotactic radiotherapy (SRT), second to fifth sessions, including adjustments, using Cyberknife or similar SRT technology - (1-5)
-
X6910
Clinical supervision of the planning of a course of simple radiotherapy - (1-5)
-
A1070
Stereotactic radiotherapy (SRT), first/sole session using Cyberknife or similar SRT technology - (1-5)
-
X0005
Clinical supervision and planning for the delivery of chemotherapy and/or systemic anti-cancer therapy for 1-56 days - (1-5)
-
X6773
Preparation for simple radiotherapy with Intensity Modulated Radiotherapy (IMRT) - (1-5)